Angiogenesis inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Angiogenesis inhibitors, covering 2024-12-27 to 2024-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer [Phase 2]